In contrast, the MYB-NFIB fusion is not expressed in non-adenoid cystic carcinoma neoplasms of the head and neck, confirming the high specificity of the MYB-NFIB fusion, which has been used as a diagnostic marker for ACC (Toper and Sarioglu, 2021). This evidence concerns the gene NFIB and neoplasm.